SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-028235
Filing Date
2021-02-25
Accepted
2021-02-25 16:10:31
Documents
3
Period of Report
2021-02-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218024d1_8k.htm 8-K 26456
2 EXHIBIT 3.1 tm218024d1_ex3-1.htm EX-3.1 6518
3 GRAPHIC ex3-1_001.jpg GRAPHIC 131460
  Complete submission text file 0001104659-21-028235.txt   215561
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 21680407
SIC: 2834 Pharmaceutical Preparations